Inside Precision Medicine January 24, 2025
A new study has found the molecular signature of Long COVID in children’s plasma and used an AI tool test capable of making the diagnosis based on the results of the blood sample, with 93% accuracy.
“The immunological data produced in this study provide the evidence needed to identify therapeutic targets to be tested in efficacy and safety studies in pediatric Long COVID,” said, co-author Nicola Cotugno at the Complex Operative Unit of Clinical Immunology and Vaccinology of the Bambino Gesù IRCCS Pediatric Hospital.
The work was done by the Università Cattolica del Sacro Cuore, Rome campus – Fondazione Policlinico Universitario Agostino Gemelli IRCCS and the Ospedale Pediatrico Bambino Gesù IRCCS.
The study was published in the journal Pediatric...
Today's Sponsors
Today's Sponsor